{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:25:54Z","timestamp":1778073954907,"version":"3.51.4"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"Importance<\/jats:title>The COVID-19 pandemic led to the use of lung transplant as a lifesaving therapy for patients with irreversible lung injury. Limited information is currently available regarding the outcomes associated with this treatment modality.<\/jats:p><\/jats:sec>Objective<\/jats:title>To describe the outcomes following lung transplant for COVID-19\u2013related acute respiratory distress syndrome or pulmonary fibrosis.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>In this cohort study, lung transplant recipient and donor characteristics and outcomes following lung transplant for COVID-19\u2013related acute respiratory distress syndrome or pulmonary fibrosis were extracted from the US United Network for Organ Sharing database from March 2020 to August 2022 with a median (IQR) follow-up period of 186 (64-359) days in the acute respiratory distress syndrome group and 181 (40-350) days in the pulmonary fibrosis group. Overall survival was calculated using the Kaplan-Meier method. Cox proportional regression models were used to examine the association of certain variables with overall survival.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Lung transplant following COVID-19\u2013related acute respiratory distress syndrome or pulmonary fibrosis.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Overall survival and graft failure rates.<\/jats:p><\/jats:sec>Results<\/jats:title>Among 385 included patients undergoing lung transplant, 195 had COVID-19\u2013related acute respiratory distress syndrome (142 male [72.8%]; median [IQR] age, 46 [38-54] years; median [IQR] allocation score, 88.3 [80.5-91.1]) and 190 had COVID-19\u2013related pulmonary fibrosis (150 male [78.9%]; median [IQR] age, 54 [45-62]; median [IQR] allocation score, 78.5 [47.7-88.3]). There were 16 instances of acute rejection (8.7%) in the acute respiratory distress syndrome group and 15 (8.6%) in the pulmonary fibrosis group. The 1-, 6-, and 12- month overall survival rates were 0.99 (95% CI, 0.96-0.99), 0.95 (95% CI, 0.91-0.98), and 0.88 (95% CI, 0.80-0.94) for the acute respiratory distress syndrome cohort and 0.96 (95% CI, 0.92-0.98), 0.92 (95% CI, 0.86-0.96), and 0.84 (95% CI, 0.74-0.90) for the pulmonary fibrosis cohort. Freedom from graft failure rates were 0.98 (95% CI, 0.96-0.99), 0.95 (95% CI, 0.90-0.97), and 0.88 (95% CI, 0.79-0.93) in the 1-, 6-, and 12-month follow-up periods in the acute respiratory distress cohort and 0.96 (95% CI, 0.92-0.98), 0.93 (95% CI, 0.87-0.96), and 0.85 (95% CI, 0.74-0.91) in the pulmonary fibrosis cohort, respectively. Receiving a graft from a donor with a heavy and prolonged history of smoking was associated with worse overall survival in the acute respiratory distress syndrome cohort, whereas the characteristics associated with worse overall survival in the pulmonary fibrosis cohort included female recipient, male donor, and high recipient body mass index.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this study, outcomes following lung transplant were similar in patients with irreversible respiratory failure due to COVID-19 and those with other pretransplant etiologies.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamasurg.2023.3489","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T15:01:19Z","timestamp":1692198079000},"page":"1159","source":"Crossref","is-referenced-by-count":11,"title":["Outcomes Following Lung Transplant for COVID-19\u2013Related Complications in the US"],"prefix":"10.1001","volume":"158","author":[{"given":"Panagiotis","family":"Tasoudis","sequence":"first","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard J.","family":"Lobo","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond D.","family":"Coakley","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris B.","family":"Agala","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Egan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin E.","family":"Haithcock","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita N.","family":"Mody","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Cardiothoracic Surgery, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"20","key":"soi230053r2","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"soi230053r3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043560","article-title":"COVID-19 case-fatality rate and demographic and socioeconomic influencers: worldwide spatial regression analysis based on country-level data.","volume":"10","author":"Cao","year":"2020","journal-title":"BMJ Open"},{"issue":"2","key":"soi230053r4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5603\/ARM.a2021.0036","article-title":"Predictors of mortality in patients with severe COVID-19 pneumonia\u2014a retrospective study.","volume":"89","author":"Mahendra","year":"2021","journal-title":"Adv Respir Med"},{"issue":"1","key":"soi230053r5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03240-7","article-title":"Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey.","volume":"24","author":"Tzotzos","year":"2020","journal-title":"Critical Care"},{"issue":"9","key":"soi230053r6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"soi230053r8","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/CM9.0000000000000839","article-title":"Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis.","volume":"133","author":"Chen","year":"2020","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"soi230053r9","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1097\/SLA.0000000000003955","article-title":"Lung transplantation for elderly patients with end-stage COVID-19 pneumonia.","volume":"272","author":"Han","year":"2020","journal-title":"Ann Surg"},{"issue":"10","key":"soi230053r10","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S2213-2600(20)30361-1","article-title":"Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient.","volume":"8","author":"Lang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"soi230053r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.103590","article-title":"Post COVID-19 pulmonary fibrosis; a meta-analysis study.","volume":"77","author":"Hama Amin","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"issue":"8","key":"soi230053r12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/ph14080807","article-title":"Lung fibrosis after COVID-19: treatment prospects.","volume":"14","author":"Bazdyrev","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"soi230053r13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2147\/PROM","article-title":"Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives.","volume":"9","author":"Graney","year":"2018","journal-title":"Patient Relat Outcome Meas"},{"issue":"1","key":"soi230053r14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12931-019-1161-4","article-title":"Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat.","volume":"20","author":"Maher","year":"2019","journal-title":"Respir Res"},{"issue":"8","key":"soi230053r15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"7","key":"soi230053r16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jama.2022.0204","article-title":"Clinical characteristics and outcomes of patients with COVID-19-associated acute respiratory distress syndrome who underwent lung transplant.","volume":"327","author":"Kurihara","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"soi230053r17","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1111\/tri.v34.12","article-title":"COVID-19 in lung transplant recipients: an overview of the Swedish national experience.","volume":"34","author":"Magnusson","year":"2021","journal-title":"Transpl Int"},{"issue":"574","key":"soi230053r18","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1126\/scitranslmed.abe4282","article-title":"Lung transplantation for patients with severe COVID-19.","volume":"12","author":"Bharat","year":"2020","journal-title":"Sci Transl Med"},{"issue":"1","key":"soi230053r19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/crj.v16.1","article-title":"Graft dysfunction and rejection of lung transplant, a review on diagnosis and management.","volume":"16","author":"Sun","year":"2022","journal-title":"Clin Respir J"},{"issue":"10","key":"soi230053r20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.healun.2017.07.020","article-title":"Report of the International Society for Heart and Lung Transplantation Working Group on Primary Lung Graft Dysfunction, part II: epidemiology, risk factors, and outcomes\u2014a 2016 consensus group statement of the International Society for Heart and Lung Transplantation.","volume":"36","author":"Diamond","year":"2017","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"soi230053r21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19.","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"soi230053r22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S2213-2600(21)00077-1","article-title":"Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries.","volume":"9","author":"Bharat","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"10","key":"soi230053r23","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2213-2600(20)30393-3","article-title":"When to consider lung transplantation for COVID-19.","volume":"8","author":"Cypel","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"9","key":"soi230053r24","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00288-5","article-title":"Lung transplantation for COVID-19-associated ARDS\u2014authors\u2019 reply.","volume":"9","author":"Bharat","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"6","key":"soi230053r25","doi-asserted-by":"publisher","first-page":"e870","DOI":"10.1097\/SLA.0000000000004623","article-title":"Comment on \u201cLet\u2019s Build Bridges to Recovery in COVID-19 ARDS, not Burn Them!\u201d.","volume":"274","author":"Machuca","year":"2021","journal-title":"Ann Surg"},{"issue":"7","key":"soi230053r26","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","article-title":"Coronavirus pandemic (COVID-19).","volume":"5","author":"Mathieu","year":"2020","journal-title":"Our World in Data"},{"key":"soi230053r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2022.09.039","article-title":"A matched survival analysis of lung transplant recipients with coronavirus disease 2019-related respiratory failure.","author":"Freischlag","year":"2022","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"soi230053r28","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.athoracsur.2010.07.073","article-title":"Comparison of outcomes from smoking and nonsmoking donors: thirteen-year experience.","volume":"90","author":"Berman","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"soi230053r29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/01.TP.0000131975.98323.13","article-title":"A donor history of smoking affects early but not late outcome in lung transplantation.","volume":"78","author":"Oto","year":"2004","journal-title":"Transplantation"},{"issue":"1","key":"soi230053r30","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1016\/S1053-2498(02)00822-7","article-title":"Impact of donor smoking on survival after lung transplantation.","volume":"22","author":"Waddell","year":"2003","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"soi230053r31","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/j.jtcvs.2017.11.031","article-title":"Association of body mass index with lung transplantation survival in the United States following implementation of the lung allocation score.","volume":"155","author":"Fernandez","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"soi230053r32","doi-asserted-by":"publisher","first-page":"S417","DOI":"10.1016\/j.healun.2019.01.1062","article-title":"Outcomes of donor-recipient gender mismatched lung transplantation in the Eurotransplant area.","volume":"38","author":"van Erp","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"10307","key":"soi230053r33","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/S0140-6736(21)01960-7","article-title":"Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.","volume":"398","author":"Barbaro","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"soi230053r34","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.healun.2021.03.015","article-title":"Incidence and impact of primary graft dysfunction in adult heart transplant recipients: a systematic review and meta-analysis.","volume":"40","author":"Buchan","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"soi230053r35","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jtcvs.2018.03.112","article-title":"A single-center experience of 1500 lung transplant patients.","volume":"156","author":"Balsara","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"soi230053r36","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/MAT.0000000000001350","article-title":"Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation.","volume":"67","author":"Harano","year":"2021","journal-title":"ASAIO J"},{"issue":"4","key":"soi230053r37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.healun.2005.11.436","article-title":"Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.","volume":"25","author":"Prekker","year":"2006","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"soi230053r38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40001-022-00655-6","article-title":"Major coagulation disorders and parameters in COVID-19 patients.","volume":"27","author":"Teimury","year":"2022","journal-title":"Eur J Med Res"},{"issue":"6","key":"soi230053r39","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/s00134-020-06031-4","article-title":"Platelets and extra-corporeal membrane oxygenation in adult patients: a systematic review and meta-analysis.","volume":"46","author":"Jiritano","year":"2020","journal-title":"Intensive Care Med"},{"key":"soi230053r1","unstructured":"US Centers for Disease Control and Prevention. COVID-19 timeline. Accessed October 31, 2022. https:\/\/www.cdc.gov\/museum\/timeline\/covid19.html"},{"key":"soi230053r7","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Accessed October 31, 2022. https:\/\/covid19.who.int\/"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2808478\/jamasurgery_tasoudis_2023_oi_230053_1699372346.383.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T16:07:22Z","timestamp":1699459642000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2808478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2023.3489","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}